CSD
Invesco S&P Spin-Off ETF
SMB
Adj. R2
0.833
Rel. Sharpe
0.927
Mkt beta
1.13
AUM
US$114M
MER
0.67%
Valuation
420
ETF comparison
Verified factor-similar pair
CSD vs PRFZ
These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.
SMB
Similarity score
86
Verified similar
The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.
Quick Read
- PRFZ has the higher backtested relative Sharpe (0.963 vs 0.927).
- PRFZ has the lower published fee (0.34% vs 0.67%).
- PRFZ is cheaper on dividend valuation (153 vs 420, where 100 is each fund's historical median).
- PRFZ has the stronger regression fit (adjusted R-squared 0.974 vs 0.833).
These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.
PRFZ
Invesco RAFI US 1500 Small-Mid ETF
SMB
Adj. R2
0.974
Rel. Sharpe
0.963
Mkt beta
1.02
AUM
US$2.7B
MER
0.34%
Valuation
153
Factor Exposure Match
Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.
SMB
diff -0.30
HML
diff -0.03
RMW
diff +0.06
CMA
diff -0.03
UMD
diff +0.07
Why This Pair Matches
Exposure level
84
Exposure shape
99
Mkt beta diff
0.10
Rel. Sharpe diff
0.036
This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.
Monthly updates
Get the next US ETF leaders update
Get one monthly email when the US leaders table refreshes, plus methodology and comparison-page updates.
Monthly leaders refresh
Download-access updates
Low-volume research notes
One monthly email when the data drop lands. This browser will remember you after signup.